Raptor localization predicts prognosis and tamoxifen response in estrogen receptor-positive breast cancer.

ABSTRACT:

Purpose

Deregulated PI3K/mTOR signals can promote the growth of breast cancer and contribute to endocrine treatment resistance. This report aims to investigate raptor and its intracellular localization to further understand its role in ER-positive breast cancer.

Methods

Raptor protein expression was evaluated by immunohistochemistry in 756 primary breast tumors from postmenopausal patients randomized to tamoxifen or no tamoxifen. In vitro, the MCF7 breast cancer cell line and tamoxifen-resistant MCF7 cells were studied to track the raptor signaling changes upon resistance, and raptor localization in ER?-positive cell lines was compared with that in ER?-negative cell lines.

Results

Raptor protein expression in the nucleus was high in ER/PgR-positive and HER2-negative tumors with low grade, features associated with the luminal A subtype. Presence of raptor in the nucleus was connected with ER? signaling, here shown by a coupled increase of ER? phosphorylation at S167 and S305 with accumulation of nuclear raptor. In addition, the expression of ER?-activated gene products correlated with nuclear raptor. Similarly, in vitro we observed raptor in the nucleus of ER?-positive, but not of ER-negative cells. Interestingly, raptor localized to the nucleus could still be seen in tamoxifen-resistant MCF7 cells. The clinical benefit from tamoxifen was inversely associated with an increase of nuclear raptor. High cytoplasmic raptor expression indicated worse prognosis on long-term follow-up.

Conclusion

We present a connection between raptor localization to the nucleus and ER?-positive breast cancer, suggesting raptor as a player in stimulating the growth of the luminal A subtype and a possible target along with endocrine treatment.

SUBMITTER: Bostner J 

PROVIDER: S-EPMC5847064 | biostudies-literature | 2018 Feb

REPOSITORIES: biostudies-literature